Cipro HC 0.2 % / 1 % Otic Suspension
RxNorm 213320
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 213320 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Cipro HC 0.2 % / 1 % Otic Suspension.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SYPrescribable
Synonym (SY):
Cipro HC (ciprofloxacin 0.2 % / hydrocortisone 1 % ) Otic Suspension
(Atom ID: 3608544)
PSNPrescribable
Prescribable Name (PSN):
Cipro HC 0.2 % / 1 % Otic Suspension
(Atom ID: 6406955)
SYPrescribable
Synonym (SY):
Cipro HC 2/10 Otic Suspension
(Atom ID: 2975667)
SBDPrescribable
Semantic Branded Drug (SBD):
Ciprofloxacin 2 mg/ML / hydrocortisone 10 mg/ML Otic Suspension [Cipro HC]
(Atom ID: 12356060)
Patient Education
Ciprofloxacin and Hydrocortisone Otic
Ciprofloxacin and hydrocortisone otic is used to treat outer ear infections in adults and children. Ciprofloxacin is in a class of medications called quinolone antibiotics. Hydrocortisone is in a class of medications called corticosteroids. The combination of ciprofloxacin and hydrocortisone works by killing the bacteria that cause infection and reducing swelling in the ear.
[Learn More]
* Please review the disclaimer below.